Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Is a |
Oral caffeine (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Is a |
Product containing butalbital and paracetamol (medicinal product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Butalbital (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesics |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Is a |
Product containing paracetamol in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Is a |
Product containing caffeine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing butalbital and caffeine and paracetamol (medicinal product) |
Is a |
Caffeine- and paracetamol-containing product |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|